Infliximab (Remicade) Biosimilars — Save Thousands
FDA-approved biosimilars for Infliximab (Remicade) offer the same efficacy and safety at up to 60% lower cost — saving up to $6,000/year. Script Unlock connects you with pharmacies offering biosimilar pricing.
Reference product
$10,000
Infliximab (Remicade)
Biosimilar price
from $4,000
save up to 60%
FDA-Approved Infliximab (Remicade) Biosimilars
InflectraRenflexisAvsolaIxifi
Are Biosimilars as Effective as Infliximab (Remicade)?
- FDA requires biosimilars to have no clinically meaningful differences in safety or efficacy
- Same active ingredient, same mechanism of action
- Interchangeable biosimilars can be substituted without prescriber intervention
- Extensive clinical studies required before FDA approval